Etoricoxib Adult Dosage
The recommended adult dosage of etoricoxib is condition-specific: 60 mg once daily for osteoarthritis, 90 mg once daily for rheumatoid arthritis, and 120 mg once daily for acute gout, with treatment duration kept as short as possible due to cardiovascular risks inherent to all COX-2 selective inhibitors 1, 2.
Dosing by Indication
Osteoarthritis
- 60 mg once daily is the established dose for osteoarthritis 1, 3, 4
- Clinical trials demonstrated maximal efficacy at 60 mg, with no additional benefit from higher doses 3
- This dose provides sustained pain relief comparable to ibuprofen 2400 mg/day and superior to placebo 4
Rheumatoid Arthritis
- 90 mg once daily is the recommended dose 1, 5
- While 60 mg shows efficacy, 90 mg provides statistically significant additional pain relief, though the clinical difference is modest 5
- Both doses demonstrate superior efficacy compared to placebo on Disease Activity Score (DAS28-CRP) and pain assessments 5
- Important caveat: Dose escalation from 60 mg to 90 mg in patients with inadequate pain response does not significantly improve outcomes, so starting at the appropriate dose is preferable 5
Acute Gout
- 120 mg once daily for 8 days is the validated regimen 1, 2
- This dose demonstrates comparable efficacy to indomethacin 50 mg three times daily but with significantly fewer drug-related adverse events (16.5% vs 37.2%) 2
Chronic Low Back Pain
- 60 mg once daily has been studied and shows efficacy comparable to diclofenac 150 mg/day 6
Critical Safety Considerations
All COX-2 selective inhibitors, including etoricoxib, carry a class effect of increased cardiovascular risk 7. The 2007 American Heart Association scientific statement documented a rate ratio of 1.86 (95% CI 1.33-2.59) for myocardial infarction with COX-2 inhibitors versus placebo 7.
Prescribing Principles
- Use the lowest effective dose for the shortest duration necessary
- Fully inform high-risk cardiac patients about excess cardiovascular risks before initiating therapy 7
- Reserve use for patients who have not achieved adequate pain control with other analgesics
- Avoid in patients with established cardiovascular disease when possible
Practical Administration
- Etoricoxib can be taken without regard to meals
- Once-daily dosing improves adherence compared to multiple-daily-dose NSAIDs
- Maximum treatment duration should be limited; for acute conditions like gout, restrict to 8 days 2
Common Pitfalls to Avoid
- Do not start at 90 mg for osteoarthritis - 60 mg provides maximal efficacy and unnecessary higher dosing only increases cardiovascular risk 3
- Do not escalate doses mid-treatment for inadequate response in RA - this strategy has not proven effective 5
- Do not use indefinitely - the cardiovascular risk accumulates with duration of exposure 7